We are a COVID-19 Testing Facility

Are you interested in taking part in a clinical trial for Idiopathic Pulmonary Fibrosis?

We are currently looking for participants who have a documented diagnosis of Idiopathic Pulmonary Fibrosis (IPF) and are 40 years or older.

The study will be investigating whether a study treatment called CSL312 will be effective in participants who have IPF over a 14 week study treatment period.

Who can join?

You may be suitable for the study if you:

What will the study involve?

During the study you will be asked to:

If you are interested in taking part in this study, please contact us for more information


9730 S. Western Ave., Suite 218
Evergreen Park, IL 60805